Sativex (nabiximols) — a cannabis-based oral spray used to ease spasticity in certain people with multiple sclerosis (MS) — has been acquired by CNX Therapeutics, which will now market the […]
The post Sativex MS spasticity spray now with CNX Therapeutics after sale appeared first on Multiple Sclerosis News Today.
Source: multiplesclerosisnewstoday.com